Abiopharma

🔍 KOUNINIS EFSTATHIOS A (Executive)

Company: PEGASYSTEMS INC (PEGA)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 2,500 shares of Common stock at $16.95 per share (Direct)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,509.00 | transaction_form_type: 4
• Sold 1,488 shares of Common stock at $36.5 per share (Direct)
  Date: 2026-08-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,021.00 | transaction_form_type: 4
• Sold 1,012 shares of Common stock at $36.5 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,009.00 | transaction_form_type: 4
• Acquired 206 shares of Common stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,215.00 | transaction_form_type: 4
• Sold 51 shares of Common stock at $36.81 per share (Direct)
  Date: 2026-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,164.00 | transaction_form_type: 4
• Sold 2,500 shares of Stock Options at $16.95 per share (Derivative)
  Date: 2026-08-31 | Code: M | Expires: 2032-11-02 | Exercise: 2023-02-02 | equity_swap_involved: 0 | shares_owned_after: 9,300.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 206 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | Expires: 2027-03-01 | Exercise: 2023-03-01 | equity_swap_involved: 0 | shares_owned_after: 412.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Options will vest in equal quarterly amounts over a four year period with the first vest occurring on February 2, 2023.
• F2: Each restricted stock unit represents the right to receive, following vesting, one share of common stock.
• F3: 20% of the restricted stock units vested on the Date Exercisable in Table II, and the remaining 80% vest in equal quarterly installments over the following four years.